Trinity Biotech plc (TRIB)

Trinity Biotech Revenue

In the year 2025, Trinity Biotech had annual revenue of $43.79M, down -28.87%. Trinity Biotech had revenue of $11.07M in the quarter ending December 31, 2025. That makes Trinity Biotech the 28,895th largest company in the world by revenue and 3,875th in the United States.

• Revenue (ttm): $43.79M
• Revenue Growth: -28.87%
• P/S Ratio: 0.15
• Revenue / Employee: $152,561
• Employees: 287
• Market Cap: 6.66M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Clinical Laboratory Goods 31.68M 72.3%
• Point-Of-Care Products 8.10M 18.5%
• Clinical Laboratory Services 4.01M 9.1%

By Geography

Chart

• Americas 51.98M 77.6%
• Rest of World – Ireland 15.00M 22.4%

Fiscal year ended Dec 31, 2025 See the full Trinity Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	43.79M	-17.77M	-28.87%
Dec 31, 2024	61.56M	4.72M	8.31%
Dec 31, 2023	56.83M	-5.69M	-9.10%
Dec 31, 2022	62.52M	-18.63M	-22.96%
Dec 31, 2021	81.15M	-20.83M	-20.43%

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error